[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366381-105":59,"doc-detail-366381-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","a-scoping-review-a-scoping-review-mapping-trans-and-gender-diverse-peoples-representation-in-cancer-research","A Scoping Review - A Scoping Review Mapping Trans* and Gender Diverse People's Representation in Cancer Research","","Trans* and gender diverse people (TGD) face inequities across the cancer continuum, yet cancer-focused knowledge syntheses remain limited. This scoping review uses a mixed methods approach to map how cancer affects TGD people, extracting cancer type and continuum phase, how gender is operationalized, key findings, and TGD engagement. JBI meta-aggregation integrates qualitative narrative interpretations with pooled extracted evidence, supporting identification of terminology variation and research gaps.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-scoping-review-a-scoping-review-mapping-trans-and-gender-diverse-peoples-representation-in-cancer-research/366381/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-scoping-review-a-scoping-review-mapping-trans-and-gender-diverse-peoples-representation-in-cancer-research/366381.png","ImageObject",300,407,{"name":92,"@type":93},"eBook King","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-10","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":14},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the purpose of this scoping review?","Question",{"text":112,"@type":113},"To map how cancer affects trans* and gender diverse (TGD) people across the cancer continuum and identify evidence gaps to support more inclusive, evidence-based cancer care.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were studies selected and synthesized?",{"text":117,"@type":113},"A mixed methods scoping review was conducted, extracting cancer type and continuum phase, operationalization of gender, results, and TGD engagement. The review followed JBI’s meta-aggregation approach by qualitizing quantitative data through narrative interpretation and pooling.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the main findings about evidence coverage?",{"text":121,"@type":113},"The review included 55 studies for data extraction and found substantial variation in terminology used to describe TGD people, limited data breadth affecting generalizability, and few studies examining cancer outcomes or experiences during diagnosis and survivorship.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366381,1790165069,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":14,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":129,"read_time":144,"preview_page_count":19,"preview_urls":145},962088006270,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Cancer Medicine  \n| \u003Cbr> REVIEW  OPEN ACCESS \u003Cbr>A Scoping Review Mapping Trans* and Gender Diverse People's Representation in Cancer Research\u003Cbr>Morgan Stirling1  | Michaela A. Bourque2 | Mikayla Hunter1 | John Queenan3 | Claire Ludwig4 | Janice Ristock5 | Lyndsay Harrison6 | Amanda Ross-White7 | Nathan C. Nickel8 | Annette Schultz2 | Versha Banerji9,10 | Jacqueline Gahagan11 | Alyson Mahar3 \u003Cbr>1Faculty of Health Sciences, Community Health Sciences, University of Manitoba Rady, Winnipeg, Manitoba, Canada | 2Faculty of Health Sciences, College of Nursing, University of Manitoba Rady, Winnipeg, Manitoba, Canada | 3School of Nursing, Queen's University, Kingston, Ontario,\u003Cbr>Canada | 4The Ottawa Hospital, The University Ottawa, Ottawa, Ontario, Canada | 5Women's and Gender Studies Program, University of Manitoba, Winnipeg, Manitoba, Canada | 6Palliative Care Division, Bruyère Health Research Institute, Ottawa, Ontario, Canada | 7Queen's University, Kingston, Ontario, Canada | 8Faculty of Health Sciences, Manitoba Centre for Health Policy, Community Health Sciences, University of Manitoba Rady, Winnipeg, Manitoba, Canada | 9Faculty of Health Sciences, Max Rady College of Medicine, Internal Medicine, University of Manitoba Rady, Winnipeg, Manitoba, Canada | 10Paul Albrechtsen Research Institute CancerCare Manitoba, Winnipeg, Manitoba, Canada | 11Research Office, Mount Saint Vincent University, Halifax, Nova Scotia, Canada\u003Cbr>Correspondence: Morgan Stirling ([umstirli@myumanitoba.ca](umstirli@myumanitoba.ca))\u003Cbr>Received: 2 October 2024 | Revised: 29 January 2025 | Accepted: 7 March 2025\u003Cbr>Funding: This work was supported by Canadian Cancer Society, Mahar; Grant \\#707149. Canadian Institutes of Health Research, Stirling, Grant \\#175933 .\u003Cbr>Keywords: cancer | gender minorities | health equity | scoping review | trans and gender diverse people |\n| --- |\n| ABSTRACT\u003Cbr>Introduction: Trans* and gender diverse people (TGD) are at risk of experiencing inequities across the cancer continuum. While limited evidence suggests cancer is a concern for TGD people, few systematic reviews or other knowledge syntheses exist that can guide efforts to improve the evidence base and address the inequities TGD people face in cancer care.\u003Cbr>Methods: Our team conducted a mixed methods scoping review exploring how cancer affects TGD people. We extracted data on cancer type and phase of the cancer continuum, gender definition operationalization, results, and TGD engagement. We followed JBI's meta-aggregation approach for mixed methods reviews by qualitizing quantitative data through narrative interpretation and pooling to integrate the extracted data.\u003Cbr>Results: A search of multiple databases yielded 5986 titles after de-duplication. Reviewers independently screened titles and abstracts and identified 511 citations for full text review, and 55 were included for data extraction. Thirty studies reported on cancer screening, most of which focused on sex-based cancers. There was significant variation in terminology used to describe TGD people. We observed a lack of breadth in data used among included studies, limiting the generalizability of results. Six studies engaged TGD people. Few studies investigated cancer outcomes or experiences during the diagnosis and survivorship phases; few focused on survival or mortality outcomes.\u003Cbr>Conclusion: We observed significant gaps in the body of research on TGD people and cancer. Efforts to improve the evidence base are needed to address knowledge gaps about TGD people's cancer experiences and outcomes and ensure the delivery of inclusive, evidence-based cancer care is possible. |\n|  |\n| MEGAN-CAN Team: Natalie Coburn, Sunnybrook Health Sciences Centre. Jeff Crane, Memorial University of Newfoundland. Laura Davis, McGill University. David Dawe, CancerCare Manitoba. Kathleen Decker, University of Manitoba. Julie Deleemans, University of Calgary. Marshall Pitz, University of Manitoba. Donna Turner, University of Manit","cbCaipKT7zinClQs","https://ap.wps.com/l/cbCaipKT7zinClQs","pdf",505872,14,"English","# Abstract\n## Introduction\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Background and inequities across the cancer continuum\n## Manifestations of cisnormativity and cissexism in cancer care","[{\"question\":\"What was the purpose of this scoping review?\",\"answer\":\"To map how cancer affects trans* and gender diverse (TGD) people across the cancer continuum and identify evidence gaps to support more inclusive, evidence-based cancer care.\"},{\"question\":\"How were studies selected and synthesized?\",\"answer\":\"A mixed methods scoping review was conducted, extracting cancer type and continuum phase, operationalization of gender, results, and TGD engagement. The review followed JBI’s meta-aggregation approach by qualitizing quantitative data through narrative interpretation and pooling.\"},{\"question\":\"What were the main findings about evidence coverage?\",\"answer\":\"The review included 55 studies for data extraction and found substantial variation in terminology used to describe TGD people, limited data breadth affecting generalizability, and few studies examining cancer outcomes or experiences during diagnosis and survivorship.\"}]","A Scoping Review - A Scoping Review Mapping Trans* and Gender Diverse People's Representation in Cancer Research | PDF",35,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b0c5dc1185735b49fbce1ed0595772fe.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/140bddaf4defcfd9008e33af65ed1dca.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8697139bf01c2db0f910502c34eae7a2.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3c1ca8dd9ce8fe44b309afe14e386356.webp",980,1287]